Similar research also reported that SPINK1 expression in HCC cells was associated with HCC via activating the c-Raf/MEK/ERK pathway, which suggested that inhibiting the MEK pathway and usage of selumetinib could be a potential treatment strategy for HCC(37). Here, RAF1 is linked to hepatocellular carcinoma.